Acquiring Company
Merck
Acquired Company
Harpoon Therapeutics
RahwaySouth San FranciscoManufacturingBiotechnologyHealthcareHealth CareBiotechnologyPharmaceutical ManufacturingDescription
Merck has successfully acquired Harpoon Therapeutics for USD 680 million. This acquisition transforms Harpoon into a wholly owned subsidiary of Merck, enhancing its oncology pipeline with innovative cancer treatment technology. Harpoon's stock has exited Nasdaq as a result of the transaction.
Other recent acquisitions in Healthcare and Pharmaceutical Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Western Microsurgical acquires Q Surgical and Proficient Surgical (October 27, 2026)
- SpyGlass Pharma, Inc. Acquires Santen Holdings US, Inc. (October 1, 2026)
- Lifecore Biomedical, Inc. Enters Merger Agreement with Lifecore Inc. (September 28, 2026)
- Vantive Enters Agreement to Divest Majority of Hemodialysis Assets to Rockwell Medical to Focus on Home Dialysis. (November 4, 2026)
- BioAdaptives, Inc. to acquire Xycota Biosciences LLC to Expand Biotechnology Portfolio (November 4, 2026)
- Rockwell Medical, Inc. to Acquire Vantive Limited's Hemodialysis Business (November 3, 2026)
Who to call at Merck, and when
When Merck changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Merck raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Merck, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Merck. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Merck makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Harpoon Therapeutics?
Harpoon Therapeutics was acquired by Merck, based in Rahway. The deal was reported on September 24, 2026. Merck is publicly traded (MRK) and operates in Manufacturing.
When did Merck acquire Harpoon Therapeutics?
Merck's acquisition of Harpoon Therapeutics was reported on September 24, 2026. Merck has successfully acquired Harpoon Therapeutics for USD 680 million. This acquisition transforms Harpoon into a wholly owned subsidiary of Merck, enhancing its oncology pipeline with innovative cancer treatment technology. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Harpoon Therapeutics do?
Harpoon Therapeutics is a clinical-stage immuno-oncology company developing a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. It is privately held, operating in Biotechnology, and is based in South San Francisco.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.